AI vs. Dog Cancer, Oscars Reactions, How to Lose the AI Arms Race | Kevin Espiritu, Paul Conyngham, Tony Zhao, Drew Oetting, Carina Hong, Cameron Fink, Debra Birnbaum

March 16, 2026

AI Summary

5 min read

The episode examines how AI tools are moving from abstract capabilities into concrete applications across health, culture, and national strategy, while highlighting the practical frictions that remain.

AI in Veterinary Oncology

A detailed case involved Paul Conyngham, who used ChatGPT to guide the creation of a personalized mRNA vaccine for his dog Rosie's mast cell cancer after conventional treatments failed. The workflow began with tumor and healthy DNA sequencing at the University of New South Wales, followed by custom pipelines to identify mutations such as those in the KIT gene. AlphaFold modeled protein structures, and docking simulations plus genetic algorithms screened existing compounds. When a promising drug proved unavailable through compassionate-use channels, the team shifted to mRNA design. The university RNA institute produced a nanoparticle vaccine that reduced one tumor by roughly half and improved the dog's quality of life, though it did not eliminate the disease.

Continue reading the full summary in the app — free to try.

Read Full Summary →

Free • No credit card required

Listen to Audio Summary Open in App

What you'll learn

1 (00:17) **Travis Kalanick Interview Reactions** - Hosts recap positive feedback and cultural impact from the prior week's interview.
2 (06:01) **Paul Conyngham Dog Cancer Story** - Detailed breakdown of the Australian entrepreneur's use of ChatGPT to help design a custom mRNA vaccine for his dog's mast cell cancer.
3 (12:38) **Freeman Dyson Biotech Future Context** - Hosts connect the story to Dyson's 2007 essay on domesticated biotechnology and the blurring line between institutions and motivated individuals.
4 (21:00) **Nvidia GTC Keynote Highlights** - Quick coverage of Jensen Huang's remarks on CUDA's 20-year history and AI infrastructure demand.
5 (23:22) **Ash Jillard Post on AI + Biotech** - Analysis of how the dog story illustrates AI compressing complex genomics and mRNA design pipelines for individuals.
6 (40:05) **Ben Thompson Stratechery Post** - Hosts review the argument that current AI demand (reasoning models + agents) justifies hyperscaler capex and is not a bubble.
7 (52:20) **Apollo's John Zito on Private Markets** - Discussion of Zito's comments on arrogance in private credit, software company valuations, and expected markdowns.

+ Full timestamped outline available in the app

Show Notes

(05:56) - AI vs Dog Cancer
(20:45) - 𝕏 Timeline Reactions
(40:20) - Stratechery: "Agents Over Bubbles"
(01:01:08) - 𝕏 Timeline Reactions
(01:06:35) - How to Lose the AI Arms Race
(01:14:28) - 𝕏 Timeline Reactions
(01:22:54) - Oscars Reactions
(01:31:04) - Kevin Espiritu, founder and CEO of Epic Gardening, is a self-taught gardener who has built the world's most-followed gardening brand, offering educational content across multiple platforms and selling curated gardening products. In the conversation, he discusses breeding rare Costa Rican tree frogs, his journey from creating content to developing products, and the challenges of scaling his business, including hiring a president to manage operations.
(01:57:34) - Paul Conyngham, an Australian tech entrepreneur and AI consultant, discusses his journey in developing a personalized mRNA vaccine to treat his dog Rosie's cancer. After traditional treatments failed, he utilized AI tools like ChatGPT and AlphaFold to analyze Rosie's DNA, identify mutations, and design a vaccine construct. Collaborating with researchers, he navigated ethical approvals and manufacturing challenges, ultimately administering the vaccine, which led to a significant reduction in Rosie's tumor size.
(02:13:20) - 𝕏 Timeline Reactions
(02:21:11) - Tony Zhao, CEO of Sunday Robotics, discusses the company's shift from demos to real-world deployments, focusing on household tasks like laundry and cleaning. He highlights their innovative data collection method using gloves that mirror the robot's hand movements, enabling diverse and high-quality data collection from users' homes. Additionally, Zhao mentions their recent $165 million Series B funding, emphasizing their commitment to advancing physical intelligence and expanding into various environments beyond homes.
(02:30:54) - Drew Oetting, a founding partner at 8VC, focuses on investments across various stages and sectors, including vertical software, health delivery, and biomanufacturing. He discusses 8VC's early investment in Quince, highlighting the founder's impressive vision and the company's rapid growth, particularly post-COVID, achieving significant repeat ordering rates and cash generation. Oetting also explores the transformative impact of AI on direct-to-consumer retail, emphasizing its role in enhancing supply chain efficiency and operational margins, and reflects on the evolving startup landscape, noting the potential for high-margin businesses driven by AI advancements.
(02:43:06) - Carina Hong, founder and CEO of Axiom Math, discusses her background in mathematics and physics from MIT, her company's mission to develop mathematical superintelligence as a pathway to verified superintelligence, and the integration of post-training reasoning with formal verification to achi